154 related articles for article (PubMed ID: 28946152)
1. Percutaneous Treatment of Malignant Liver Lesions: Evaluation of Success Using Contrast- Enhanced Ultrasound (CEUS) and Perfusion Software.
Wiesinger I; Wiggermann P; Zausig N; Beyer LP; Salzberger B; Stroszczynski C; Jung EM
Ultraschall Med; 2018 Aug; 39(4):440-447. PubMed ID: 28946152
[TBL] [Abstract][Full Text] [Related]
2. Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies.
Rennert J; Wiesinger I; Beyer LP; Schicho A; Stroszczynski C; Wiggermann P; Jung EM
Clin Hemorheol Microcirc; 2019; 73(1):73-83. PubMed ID: 31561352
[TBL] [Abstract][Full Text] [Related]
3. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results.
Wiesinger I; Beyer LP; Zausig N; Verloh N; Wiggermann P; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2018; 69(1-2):59-67. PubMed ID: 29758936
[TBL] [Abstract][Full Text] [Related]
5. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
[TBL] [Abstract][Full Text] [Related]
6. Quantification of dynamic contrast-enhanced ultrasound (CEUS) in non-cystic breast lesions using external perfusion software.
Jung EM; Jung F; Stroszczynski C; Wiesinger I
Sci Rep; 2021 Sep; 11(1):17677. PubMed ID: 34480040
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
8. VueBox® perfusion analysis of contrast-enhanced ultrasound (CEUS) examinations in patients with primary hyperparathyroidism for preoperative detection of parathyroid gland adenoma.
Platz Batista da Silva N; Jung EM; Jung F; Schlitt HJ; Hornung M
Clin Hemorheol Microcirc; 2018; 70(4):423-431. PubMed ID: 30347604
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
[TBL] [Abstract][Full Text] [Related]
10. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
[TBL] [Abstract][Full Text] [Related]
11. Color coded perfusion imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following trans-arterial chemoembolization (TACE) of hepatocellular carcinoma.
Rennert J; Wiesinger I; Schicho A; Beyer LP; Wiggermann P; Stroszczynski C; Jung EM
PLoS One; 2019; 14(6):e0217599. PubMed ID: 31181127
[TBL] [Abstract][Full Text] [Related]
12. Analysis of arterial dynamic micro-vascularization with contrast-enhanced ultrasound (CEUS) in thyroid lesions using external perfusion software: First results.
Wiesinger I; Kroiss E; Zausig N; Hornung M; Zeman F; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2016; 64(4):747-755. PubMed ID: 27792004
[TBL] [Abstract][Full Text] [Related]
13. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
[TBL] [Abstract][Full Text] [Related]
14. Can different regions of interest influence the diagnosis of benign and malignant breast lesions using quantitative parameters of contrast-enhanced sonography?
Li J; Guo L; Yin L; Fang H; Ye W; Zhao B; Liu Y; Xu T
Eur J Radiol; 2018 Nov; 108():1-6. PubMed ID: 30396640
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Liver Tumors Using Preoperative and Intraoperative Contrast-Enhanced Ultrasound (CEUS/IOCEUS) by Radiologists in Comparison to Magnetic Resonance Imaging and Histopathology.
Huf S; Platz Batista da Silva N; Wiesinger I; Hornung M; Scherer MN; Lang S; Stroszczynski C; Fischer T; Jung EM
Rofo; 2017 May; 189(5):431-440. PubMed ID: 28449169
[No Abstract] [Full Text] [Related]
16. Evaluation of dynamic effects of therapy-induced changes in microcirculation after percutaneous treatment of vascular malformations using contrast-enhanced ultrasound (CEUS) and time intensity curve (TIC) analyses.
Wiesinger I; Jung W; Zausig N; Wohlgemuth WA; Pregler B; Wiggermann P; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2018; 69(1-2):45-57. PubMed ID: 29630543
[TBL] [Abstract][Full Text] [Related]
17. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Wang D; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K
Br J Radiol; 2016 Nov; 89(1067):20160379. PubMed ID: 27626506
[TBL] [Abstract][Full Text] [Related]
18. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound.
Kong WT; Wang WP; Huang BJ; Ding H; Mao F
J Gastroenterol Hepatol; 2014 Mar; 29(3):576-80. PubMed ID: 24118042
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced ultrasound-guided radiofrequency ablation in inconspicuous hepatocellular carcinoma on B-mode ultrasound.
Kim EJ; Kim YS; Shin SK; Kwon OS; Choi DJ; Kim JH
Turk J Gastroenterol; 2017 Nov; 28(6):446-452. PubMed ID: 29086712
[TBL] [Abstract][Full Text] [Related]
20. Contrast enhanced ultrasound (CEUS) with parametric imaging after irreversible electroporation (IRE) of the prostate to assess the success of prostate cancer treatment.
Jung EM; Engel M; Wiggermann P; Schicho A; Lerchbaumer M; Stroszczynski C; Fischer T; Wiesinger I
Clin Hemorheol Microcirc; 2021; 77(3):303-310. PubMed ID: 33337354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
